Achillion Pharmaceuticals Earlier Reported Danicopan (Ach-4471) Phase 2 Combination Therapy Interim Data Showed Clinically Meaningful Improvements In Laboratory Parameters Of Pnh; End-Of-Phase 2 Meeting Activities Initiated With FDA